06.12.2012 Views

CSEM Scientific and Technical Report 2008

CSEM Scientific and Technical Report 2008

CSEM Scientific and Technical Report 2008

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A Universal Protein Assembler<br />

H. Zepik<br />

Chemical protein synthesis: a new assembler molecule for the ligation of appropriately functionalized peptides in solution. The same novel<br />

approach can also be used for the purification of proteins, which is a very relevant problem today in the pharmaceutical industry<br />

Many powerful drugs are protein-based. Examples include<br />

hormones like insulin, interferons, monoclonal antibodies,<br />

blood clotting factors. Proteins are chains of amino acids, from<br />

a few tens to several hundreds. In recent years active<br />

pharmaceutical ingredients (APIs) based on proteins have<br />

received increased attention from the pharmaceutical industry.<br />

Peptide <strong>and</strong> protein therapeutics are attractive due to their<br />

high specificity <strong>and</strong> potency <strong>and</strong> low incidence of toxicology.<br />

In contrast to small molecule drugs, protein drugs are rarely<br />

produced by chemical synthesis. The major production<br />

methods are extraction from natural sources <strong>and</strong> recombinant<br />

DNA technology. However, chemical protein synthesis offers<br />

several advantages. It is possible to modify the chain of amino<br />

acids basically at-will, e.g. to insert unnatural amino acids with<br />

specific properties, to introduce various labels, to attach<br />

polymer- <strong>and</strong> sugar-chains. In addition the final product will<br />

not be contaminated by any undesired biological material.<br />

The chemical synthesis of peptide, has made enormous<br />

progress in the last decades <strong>and</strong> it is now possible to make<br />

peptides of up to ~50 amino acids reliably <strong>and</strong> in good yield.<br />

The accumulation of side products <strong>and</strong> aggregation prevent<br />

the synthesis of longer peptides <strong>and</strong> proteins. However, most<br />

protein drugs, like monoclonal antibodies, have more than<br />

100 amino acids.<br />

To overcome this size limit, peptide segments can be ligated<br />

in solution (Figure 1). However, due to the many reactive side<br />

chains present in proteins, exclusive formation of the desired<br />

bond only is impossible to achieve, unless a chemoselective<br />

condensation is employed. This last approach has been<br />

pioneered successfully but is restricted to certain amino acids<br />

due to the chemistry.<br />

NH 3 +<br />

NH 3 +<br />

SH<br />

SH<br />

NH 3 +<br />

NH 3 +<br />

OH<br />

OH<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

O<br />

C<br />

Figure 1: Unprotected peptide segments in solution cannot be ligated<br />

efficiently due to many reactive side chains.<br />

In order to overcome this strong limitation an alternative<br />

approach which should ligate any peptide segment is being<br />

developed. It is based on a dimeric “host”-molecule, the<br />

assembler ‘A’, which recognizes <strong>and</strong> binds specific chemical<br />

“guest”-groups. These groups are attached to both ends of the<br />

ligation site (Figure 2). The role of the assembler molecule is<br />

to bring the two ends into close proximity to increase their<br />

specificity <strong>and</strong> rate of reaction. The “guest”-groups can be<br />

NH<br />

NH 3 +<br />

OH<br />

OH<br />

SH<br />

SH<br />

NH 3 +<br />

NH 3 +<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

attached to many different sites, which makes this assembler<br />

universally applicable to all possible ligation sites.<br />

NH 3 +<br />

NH 3 +<br />

Figure 2: Two functionalized peptide segments are bound by the<br />

assembler ‘A’ whereby the carboxy- <strong>and</strong> amino-termini are brought<br />

into close proximity resulting in a fast <strong>and</strong> specific ligation.<br />

The “guest”-groups can then be removed to recover the final<br />

protein product. While the attachment <strong>and</strong> later removal of the<br />

functional groups is an additional manipulation <strong>and</strong> potential<br />

complication, it offers a unique opportunity for the purification<br />

of the desired protein. Immobilizing the assembler “host”molecule<br />

on a solid support allows the selective binding of the<br />

“guest”-decorated product protein (Figure 3). Since it carries<br />

two binding sites it will bind much stronger to the support than<br />

the starting peptides or any other additives present. The latter<br />

can then be washed away, <strong>and</strong> the final protein will be<br />

obtained, after removing the “guest”-groups, in pure form.<br />

NH 3 +<br />

SH<br />

SH<br />

SH<br />

NH 3 +<br />

NH 3 +<br />

NH 3 +<br />

A<br />

OH<br />

OH<br />

OH<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

O<br />

O<br />

C NH<br />

solid support<br />

Figure 3: Strong binding of the product to the assembler immobilized<br />

on the solid support.<br />

As a conclusion, this novel approach to the ligation of peptide<br />

segments can not only be used for the synthesis of arbitrary<br />

protein molecules but it is also a promising alternate technique<br />

for protein purification, for example for APIs.<br />

NH 3 +<br />

C NH<br />

OH<br />

OH<br />

OH<br />

SH<br />

SH<br />

SH<br />

NH 3 +<br />

NH 3 +<br />

NH 3 +<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

CO 2 -<br />

69

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!